智通财经APP讯，麦澜德(688273.SH)发布股价异动公告称，公司主要从事盆底及妇产康复领域相关医 疗器械产品的研发、生产、销售，主要产品涵盖盆底及妇产康复、生殖康复和抗衰、运动康复及耗材和 信息化产品。目前运动康复产品收入占比较小，暂未对公司业绩产生重大影响。 ...

人民财讯8月12日电，麦澜德(688273)8月12日晚间发布股票交易异常波动公告，公司主要从事盆底及妇 产康复领域相关医疗器械产品的研发、生产、销售，主要产品涵盖盆底及妇产康复、生殖康复和抗衰、 运动康复及耗材和信息化产品。目前运动康复产品收入占比较小，暂未对公司业绩产生重大影响。 ...

Group 1 - The core viewpoint of the articles highlights the performance and market position of 麦澜德 in the medical device industry, showcasing its recent achievements and financial metrics [1][2] - 麦澜德's stock closed at 29.62 yuan, with a rolling PE ratio of 28.17, marking a new low in 32 days, and a total market capitalization of 29.62 billion yuan [1] - The company ranks 62nd in the medical device industry, which has an average PE ratio of 49.20 and a median of 36.56 [1][2] Group 2 - For Q1 2025, 麦澜德 reported revenue of 1.18 billion yuan, reflecting a year-on-year increase of 13.36%, and a net profit of 3985.97 million yuan, up by 9.85%, with a gross margin of 70.85% [2] - The company specializes in the research, production, sales, and services of products related to pelvic floor and obstetric rehabilitation, focusing on women's health [1] - 麦澜德 has been recognized as a "national manufacturing single champion" and is the first national-level specialized and innovative "little giant" enterprise in its field, indicating strong market competitiveness and innovation capabilities [1]

南京麦澜德医疗科技股份有限公司的主营业务是盆底及妇产康复领域相关产品的研发、生产、销售和服 务。主要产品为盆底及妇产康复产品、生殖康复产品、运动康复产品、耗材和信息化产品。公司在康复 板块中聚焦女性盆底及妇产康复，成为该领域第一个国家级专精特新"小巨人"企业。2024年3月，国家 工信部,中国工业经济联合会发布了"第八批全国制造业单项冠军企业"名单，麦澜德成功获评"全国制造 业单项冠军"，这是公司继国家级专精特新小巨人企业后取得的更高一层国家级荣誉，代表了市场以及 主管部门对麦澜德在盆底及妇产康复领域专业化发展程度,自主创新能力,经营管理水平,市场竞争力及社 会效益等方面的全面肯定。 最新一期业绩显示，2025年一季报，公司实现营业收入1.18亿元，同比13.36%；净利润3985.97万元， 同比9.85%，销售毛利率70.85%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)64麦澜德27.8128.782.1629.24亿行业平均 48.9047.004.53103.78亿行业中值36.4137.242.4046.92亿1天益医疗-1685.63-2887.291.8021.48亿2澳华内 镜 ...